We previously observed downregulation of mitochondrial oxidative phosphorylation-related protein, TMEM70, which is suggestive of disrupted cellular senescence, in GST-P-expressing (þ) proliferative lesions from early hepatocarcinogenesis stages in rats. The present study investigated the immunohistochemical relationship between TMEM70 downregulation and cellular metabolic changes in carcinogenic processes, as well as the onset of the liver cell respiratory changes after repeated hepatocarcinogen treatment in rats. At the early hepatocarcinogenesis stage in a 2-stage model, GST-P þ preneoplastic lesions showing TMEM70 downregulation also downregulated the mitochondrial ATPase, ATPB, but upregulated glycolysis-related glucose transporter member 1 (GLUT1) and glucose-6-phosphate dehydrogenase, suggesting a metabolic shift from oxidative phosphorylation to glycolysis, known as the Warburg effect. Combined downregulation of TMEM70 and ATPB increased proliferation activity in GST-P þ preneoplastic lesions, suggesting cell proliferation facilitation by reducing mitochondrial respiration. Concurrent GLUT1-upregulation and TMEM70-downregulation increased nuclear phosphorylated c-MYC þ cells in GST-P þ preneoplastic lesions, suggesting c-MYC-mediated transcription facilitation to promote glycolysis and cell proliferation. The TMEM70-related metabolic shift was enhanced in GST-P þ neoplastic lesions, suggesting a contribution to tumor progression. Conversely, the TMEM70-related metabolic shift was lacking in peroxisome proliferator-activated receptor-a agonist-induced hepatocarcinogenesis, as well as in carcinogenic processes targeting other organs. Transcript expression analysis following 28-and 90-day repeated hepatocarcinogen treatment showed downregulation of Tmem70 from day 28 and upregulation of Pkm and Myc at day 90, suggesting early onset of a catastrophic cellular senescence-related metabolic shift beginning from depressed mitochondrial respiration in the liver. These results suggest a contribution of TMEM70 downregulation to the Warburg effect, which directs tumor promotion and progression in GST-P þ -linked hepatocarcinogenesis in rats.
Evaluation of chemical carcinogenicity is crucial for assessment of chemical safety. However, standard carcinogenicity bioassays in which hundreds of rodent animals are administered test compounds over a prolonged period are time-consuming and costly. To identify early marker molecules of rat liver cell hepatocarcinogenesis, we previously reported that administration of carcinogens for 28 days induces expression changes in cell cycle-related molecules resulting in cell cycle arrest in many target organs (Kimura et al., 2016; Taniai et al., 2012a; Yafune et al., 2013) . Considering that cell cycle arrest is a typical feature of cellular senescence (Campisi, 2013) , the phenomenon observed in our previous studies suggests an increased number of liver cells undergoing senescence after repeated carcinogenic stimuli.
In our recent study, we hypothesized that epigenetic modification, such as of DNA methylation, may occur in cell populations showing growth advantages during the course of carcinogen treatment. Furthermore, genes that are hypermethylated and downregulated during the course of carcinogen treatment may become early but irreversible markers of cell responses to carcinogens (Mizukami et al., 2017) . In accordance with this hypothesis, we examined hypermethylated genes in the rat liver after treatment for 28 days with the hepatocarcinogen, thioacetamide (TAA). We used CpG island microarrays to identify early marker molecules that direct liver cells to undergo hepatocarcinogenesis. Among hypermethylated and downregulated genes, we identified Tmem70 to show increase in the number of liver cell foci downregulating immunohistochemical expression of the corresponding gene product protein, transmembrane protein 70 (TMEM70), in a subpopulation of liver cell foci immunoreactive for glutathione Stransferase placental form (GST-P), a preneoplastic liver cell lesion marker in rats (Ito et al., 1998; Shirai, 1997) . In the late stage of tumor promotion by TAA, we also found a higher incidence of TMEM70-downregulation in GST-P-positive (þ) adenomas and carcinomas compared with that in GST-P þ preneoplastic liver cell foci. Considering the role of TMEM70 in mitochondrial oxidative phosphorylation (Hejzlarov a et al., 2011) , these results indicate that epigenetic gene downregulation suppressed oxidative phosphorylation after only 28 days of hepatocarcinogen treatment to contribute to tumor development. TMEM70 is an inner mitochondrial membrane protein that might play a role in the biogenesis of mitochondrial ATP synthase, because a TMEM70 loss-of-function mutation was found in a human mitochondrial disease with ATP synthase deficiency causing lactic acidosis, cardiomyopathy, and hepatomegaly (Hejzlarov a et al., 2011) . It has been reported that cellular senescence induces an increase of mitochondrial DNA and proteins, and that senescent cells undergo cell respiration depending on mitochondrial ATP synthase for their energy supply (Passos et al., 2007) . Therefore, aberrant epigenetic downregulation of Tmem70 in the liver after repeated hepatocarcinogenic TAA treatment for 28 days may reflect an increased cell population escaping senescence in addition to those progressing to senescence. Conversely, downregulation of ATP synthase has been reported in many types of carcinoma (Isidoro et al., 2004) . In contrast, tumors show unusually high rates of glucose uptake and lactate production compared with normal tissues, even in the presence of oxygen. This is termed the "Warburg effect" (Warburg et al., 1927) . In fact, the enhanced uptake by tumors of 2-deoxy-2( 18 F)-fluoro-D-glucose in positron emission tomography scans is now exploited in clinics for diagnostic purposes (Gambhir, 2002) . In experimental hepatocarcinogenesis using rats, an increase of liver cell foci immunoreactive for glycolytic enzymes was reported for GST-P þ foci after treatment with the hepatocarcinogenic agent, N-nitrosomorpholine (Enzmann et al., 1989) . Thus, aberrant epigenetic downregulation of TMEM70 after repeated treatment with TAA may trigger escape from senescence and lead to an environment that is beneficial for cancer development through a metabolic shift from mitochondrial oxidative phosphorylation to glycolysis via disruption of mitochondrial ATP synthase. This study was performed using a 2-stage hepatocarcinogenesis model to examine the relationship between downregulation of TMEM70 and induction of glycolysis, with respect to tumor promotion and acquisition of a growth advantage for GST-P þ liver cell foci. We also examined whether TMEM70 downregulation is involved in GST-P À preneoplastic liver lesions produced by peroxisome proliferator-activated receptor (PPAR)a agonists and by proliferative lesions produced in the thyroid, urinary bladder, stomach and intestines using the carcinogenesis models in rats. Finally, to confirm our hypothesis regarding the molecular shift responsible for the Warburg effect during the early stages of hepatocarcinogen treatment, we further examined the time response of cellular metabolism-related gene expression in the liver of rats treated with hepatocarcinogens for 28 and 90 days. ) . In all experiments, 5-week-old male F344/NSIc rats were purchased from Japan SLC, Inc. (Hamamatsu, Japan) and acclimatized to a powdered basal diet (CRF-1; Oriental Yeast Co., Ltd., Tokyo, Japan) and tap water ad libitum. They were housed in plastic cages with paper chip bedding in a barriermaintained animal room on a 12 h light-dark cycle and conditioned at 23 C 6 2 C with a relative humidity of 55% 6 15%.
MATERIALS AND METHODS

Chemicals and Animals
Experimental Design
There were 7 animal experiments (Table 1) .
Experiments 1 and 2. To investigate the involvement of TMEM70 downregulation in GST-P þ liver cell foci, animals were subjected to 2-stage hepatocarcinogenesis using a medium-term liver bioassay (Ito et al., 1998; Shirai, 1997) . After a 1-week acclimatization period, all animals were initiated with a single intraperitoneal injection of DEN (200 mg/kg body weight, dissolved in saline). Two weeks later, animals were randomly divided into 5 groups consisting of 12 animals per group in Experiment 1 and 3 groups of 15 animals per group in Experiment 2. In Experiment 1, animals were provided a basal diet (DEN-alone) or a diet containing TAA at 400 ppm (DEN þ TAA), MP at 1000 ppm (DEN þ MP), BNF at 5000 ppm (DEN þ BNF) or PBO at 15,000 ppm (DEN þ PBO) for 6 weeks. In Experiment 2, animals were provided a basal diet (DEN-alone) or a diet containing FB at 3500 ppm (DEN þ FB) or PB at 500 ppm (DEN þ PB) for 8 weeks. The dose levels of TAA, MP, BNF, PBO, FB, and PB have shown to promote hepatocarcinogenesis in rats (Becker, 1983; Hayashi et al., 2012; Kitano et al., 1998; Muguruma et al., 2009; NTP, 2000; Shoda et al., 1999) . The animals were subjected to two-thirds partial hepatectomy at week 3. At week 8 (Experiment 1) or 10 (Experiment 2), all animals were euthanized by exsanguination from the posterior vena cava and abdominal aorta under CO 2 /O 2 anesthesia. Livers were immediately removed and weighed, and then liver slices (2 slices per animal) were fixed in 4% (w/v) paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) for 2 days and processed for histopathological examinations. Except for DEN þ MP group, animal samples were identical to those previously reported in Mizukami et al. (2017) .
Experiment 3. To investigate the cellular distribution of molecules in neoplastic lesions in the late stage of hepatocarcinogenesis in an initiation promotion model as used in Experiments 1 and 2, 16 animals were maintained for 30 weeks during tumor promotion phase with a drinking water containing 0.3% TAA by reference to the literature (Gervasi et al., 1989) . At week 32, all animals were sacrificed in the same way to the Experiments 1 and 2. The livers of all animals were removed and fixed in the same way to the Experiments 1 and 2, and the liver slices (1 slice per animal) containing gross neoplastic lesions were processed for histopathological examinations. Animal samples were identical to those previously reported in Mizukami et al. (2017) .
Experiment 4. To investigate the cellular distribution of TMEM70 and cellular metabolism-related molecules in GST-P -liver cell foci produced by promotion with PPARa agonists in an initiation promotion model utilizing a medium-term liver bioassay, animals were randomly divided into 3 groups consisting of 15 animals per group after initiation with DEN. Animals were provided a basal diet (DEN-alone) or a diet containing CF at 3000 ppm (DEN þ CF) or DEHP at 12,500 ppm (DEN þ DEHP) for 13 weeks during promotion phase. The dose level of CF and DEHP has shown to promote hepatocarcinogenesis in rats (Sano et al., 1999) . At the end of experiment, all animals were euthanized and the livers of all animals were removed and fixed in the same way to the Experiments 1 and 2.
Experiment 5. To investigate the cellular distribution of TMEM70 and cellular metabolism-related molecules in early proliferative lesions in the thyroid, urinary bladder, forestomach and glandular stomach of rats, animals were subjected to 2-stage carcinogenesis bioassays. After a 1-week acclimatization period, animals were divided into 6 groups consisting of 12 animals. In the animal study targeting the thyroid, all animals were initiated with a single subcutaneous injection of DHPN (2800 mg/kg body weight). One week later, animals were given drinking water with (DHPN þ SDM) or without (DHPN-alone) SDM at 1500 ppm for 4 weeks. The dose of SDM has been shown to promote induction of follicular cell carcinomas after a 13-week administration in a 2-stage model (Kemmochi et al., 2012) . In the animal study targeting the urinary bladder, all animals were initiated with BBN at 500 ppm in drinking water for 4 weeks. Animals were then given either the basal diet (BBN-alone) or a diet containing PEITC at 1000 ppm (BBN þ PEITC) for 8 weeks.
The dose of PEITC has been shown to promote induction of transitional cell carcinomas for 32-week administration in a 2-stage model . In the animal study targeting the forestomach and glandular stomach, all animals were initiated with a single gavage of MNNG (150 mg/kg body weight). One week later, animals were fed either the basal diet (MNNGalone) or a diet containing catechol at 8000 ppm (MNNG þ catechol) for 12 weeks. The dose of catechol has been shown to promote induction of both forestomach and glandular stomach carcinomas after a 51-week administration in a 2-stage model (Wada et al., 1998) . After cessation of tumor promotion, all animals were euthanized and target organs of all animals were removed and fixed in the same way to the Experiments 1 and 2. Animal samples were identical to those previously reported (Taniai et al., 2012b) .
Experiment 6. To investigate the cellular distribution of TMEM70 and cellular metabolism-related molecules in late-stage proliferative lesions in the colorectum or duodenum of rats, 27 animals were subjected to AOM-induced carcinogenesis bioassay. After a 1-week acclimatization period, animals were subjected to 3 subcutaneous injections each of AOM (15 mg/kg body weight) at 1-week intervals and then maintained for 29-35 weeks. The animals were euthanized by exsanguination under deep isoflurane anesthesia, and all colorectal and duodenal tumors developed in AOM-treated animals were removed, fixed in 10% neutral buffered formalin, and embedded in paraffin. Animal samples were identical to those previously reported (Kikuchihara et al., 2015) .
Experiment 7.
To investigate the expression levels of cellular metabolism-related genes and glycolysis-related genes in the liver of rats treated with hepatocarcinogens for up to 90 days in a scheme of repeated toxicity study, animals were randomized into 4 groups of 10 animals per group and were fed a basal diet (untreated controls) or treated with TAA at 400 ppm in a diet, MP at 1000 ppm in a diet or PMZ by oral gavage at 100 mg/kg body weight in 0.5% methylcellulose for 28 or 90 days after a 1-week acclimatization period. TAA and MP were selected as hepatocarcinogens and PMZ was selected as non-carcinogenic hepatotoxicant. The dose levels of TAA and MP were selected as tumor-inducible doses in rats (Becker, 1983; NTP, 2000) . The dose level of PMZ was selected as that induces hepatotoxicity after a 13-week administration in rats (NTP, 1993) . At the end of experiment, all animals were sacrificed and the livers of all animals were removed and sliced to fix in the same way to the Experiments 1 and 2. Small portions of liver tissue were cut into small pieces (approximately 20 mg/sample), immediately frozen in liquid nitrogen and stored at -80 C until analysis.
All procedures of this study were conducted in compliance with the Guidelines for Proper Conduct of Animal Experiments (Science Council of Japan, 1 June 2006) and according to the protocol approved by the Animal Care and Use Committee of Tokyo University of Agriculture and Technology. All efforts were made to minimize animal suffering.
Histology and Immunohistochemistry
Paraffin-embedded liver tissues were sectioned in 3-lm thick sections and stained with hematoxylin and eosin for histopathological examination, or subjected to immunohistochemistry.
Immunohistochemistry was performed using serial liver sections with the horseradish peroxidase avidin-biotin complex method utilizing the Vectastain Elite ABC Kit (Vector Laboratories Inc., Burlingame, California, USA) with the primary antibodies and 3,3 0 -diaminobenzidine/H 2 O 2 as the chromogen. All immunostained slides were counterstained with hematoxylin. To investigate the relationship of TMEM70 or cellular metabolism-related molecules with early preneoplastic liver cell lesions expressing GST-P, immunohistochemistry was performed on GST-P, TMEM70, ATP synthase, H þ transporting, mitochondrial F 1 complex, beta polypeptide (ATPB), catalyzing ATP synthesis and utilizing an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation (Luciakov a and Ku zela, 1992), 60 kDa heat shock protein, mitochondrial (HSP60), an intramitochondrial molecule present as chaperone polypeptides for their transport from the cytoplasm to the mitochondrial matrix (Okamoto et al., 2015) , solute carrier family 2, facilitated glucose transporter member 1 (GLUT1), facilitating the glucose transport across the plasma membranes of mammalian cells (Zhang and Yang, 2013 ) and glucose-6-phosphate dehydrogenase (G6PD), an enzyme playing a part in the glycolysis (Zhang and Yang, 2013) , using liver tissue samples of all groups in Experiments 1 and 2 (n ¼ 10/group). To investigate the association of expression of TMEM70 and other cellular metabolism-related molecules with late-stage neoplastic liver cell lesions expressing GST-P, distribution of immunoreactive cells for TMEM70, ATPB, GLUT1, and G6PD in relation with GST-P þ foci, adenomas and carcinomas was examined in Experiment 3 (n ¼ 10/group). To investigate the relationship between TMEM70 À liver cell foci and expression of each cellular metabolism-related molecule in combination with cell proliferation, apoptosis and gene transcription responsible for multiple functions, such as cell cycle progression, apoptosis and cellular transformation, distribution of immunoreactive cells for proliferating cell nuclear antigen (PCNA), cleaved caspase 3 and phosphorylated c-MYC was examined in TMEM70 -foci coexpressing each of cellular metabolism-related molecules in DEN þ TAA, DEN þ MP and DEN þ PBO groups of Experiment 1 (n ¼ 10/group). To investigate the association of expression of TMEM70 and other cellular metabolism-related molecules with hepatocarcinogenesis to produce proliferative liver cell lesions by promotion with PPARa agonists, distribution of immunoreactive cells for TMEM70, ATPB, GLUT1, and G6PD in relation with GST-P -foci was examined in all groups of Experiment 4 (n ¼ 10/group).
To investigate the association of expression of TMEM70 and other cellular metabolism-related molecules with carcinogenesis of organs other than the liver, distribution of immunoreactive cells for TMEM70, ATPB, GLUT1, and G6PD in relation with early proliferative lesions in the thyroid, urinary bladder and stomach was examined in all groups of Experiment 5 (n ¼ 10/ group), and late stage proliferative lesions in the colorectal and duodenal tumors in Experiment 6 (n ¼ 10).
Antigen retrieval conditions and the concentration of each antibody are shown in Supplementary Table 1. To inhibit endogenous peroxidase, deparaffinized sections were incubated in 0.3% H 2 O 2 solution in absolute methanol for 30 min. All immunostained slides were counterstained with hematoxylin.
Analysis of Immunolocalization in the Livers
The number and area of GST-P þ foci larger than 200 lm in diameter in liver sections from the Experiments 1, 2, and 7 were measured as described previously (Taniai et al., 2009) . In Experiment 3, livers were diagnosed histopathologically as foci of cellular alteration, liver cell adenomas and liver cell carcinomas as described previously (Mizukami et al., 2017) . The number of GST-P -foci larger than 200 lm in diameter in liver sections stained with hematoxylin and eosin from the Experiment 4 were measured. The immunoreactivity of TMEM70 in tissue samples from Experiments 1-6 was classified as decreased or unchanged in proliferative lesion compared with the surrounding normal areas. The immunoreactivity of ATPB, HSP60, GLUT1, and G6PD from the Experiments 1 and 2 was classified as increased (þ), unchanged (þ/-) or decreased (-) in the GST-P þ foci compared with the surrounding hepatocytes. In Experiments 1 and 2, the incidences of TMEM70
-, GLUT1 þ , and G6PD þ expression in total GST-P þ foci were estimated. In Experiment 3, the immunoreactivity of ATPB, GLUT1, and G6PD was classified as increased (þ) or decreased (-) and the incidences of TMEM70
þ , and G6PD þ expression in total GST-P þ liver cell foci, adenomas and carcinomas were estimated in the same way to the Experiments 1 and 2. Finally, incidence of ATPB -, GLUT1 þ , and G6PD
þ expression in total of TMEM70 -foci in GST- 
10 randomly selected areas at a magnification of 400Â.
Transcript Expression Analysis
Real-time RT-PCR quantification of mRNA was performed for cellular metabolism-related genes and transcription factor genes on RNA samples (n ¼ 6/group) isolated from fresh frozen liver tissue of untreated controls, and TAA-, MP-, and PMZtreated groups in Experiment 7. Total RNA was extracted with RNeasy Mini Kit (Qiagen, Hilden, Germany) and first strand cDNA was synthesized from 2 mg of total RNA using SuperScript III Reverse Transcriptase (Thermo Fisher Scientific, Waltham, Massachusetts, USA). Real-time PCR was performed using Power SYBR Green PCR Master Mix and Applied Biosystems StepOnePlus Real-Time PCR System (Thermo Fisher Scientific). PCR primers listed in Supplementary Table 2 for target genes were designed using Primer Express Software Version 3.0 (Thermo Fisher Scientific). Using the threshold cycle (C T ) values of Actb and Hprt1 in the same sample as the endogenous control, the relative differences in gene expression were calculated using the 2 ÀDDC T method (Livak and Schmittgen, 2001 ).
Statistical Analysis
Numerical data are represented as mean 6 SD. For comparison of the numerical data between multiple groups, values were analyzed by the Bartlett's test for the homogeneity of variance.
If there was no significant difference in variance, Dunnett's test was performed for comparison between the groups. If a significant difference was found in variance, Steel's test was performed. In the case of numerical data consisting of 2 sample groups, data were assessed using F-test for homogeneity of variance. If the variance was homogenous between the groups, a Student's t test was applied for comparison, and if it was heterogeneous, the Aspin-Welch's t test was performed. For incidence data of ATPB -, GLUT1
þ , and G6PD þ in GST-P þ liver cell proliferative lesions in Experiment 3, Fisher's exact probability test was performed. All analyses were conducted using an Excel Statistics 2010 software package (Social Survey Research Information Co. Ltd., Tokyo, Japan).
RESULTS
Evaluation of Proliferative Lesions
In Experiments 1 and 2, there were significantly more and larger GST-P þ foci compared with DEN-alone group after tumor promotion for 6 or 8 weeks with every hepatocarcinogen/hepatocarcinogenic tumor promoter (Supplementary Table 3 ). In Experiment 3, many adenomas and carcinomas were obtained after treatment with TAA for 30 weeks. The numbers of liver cell foci (eosinophilic), adenomas and carcinomas showing GST-P-immunoreactivity and subjected to further immunohistochemical analyses were 123, 81, and 52, respectively.
In Experiment 4, there were significantly more altered liver cell foci that have nonimmunoreactivity with GST-P compared with DEN-alone group after 13-week tumor promotion with CF and DEHP, whereas the number of GST-P þ liver cell foci was decreased after tumor promotion with CF and DEHP (Supplementary Table 4 ). With regard to tumor promotion activity in Experiment 5, we have previously reported that tumor promotion with SDM resulted in induction of focal follicular cell hyperplasias in the thyroid (Kemmochi et al., 2012) . Similarly, tumor promotion with PEITC resulted in induction of simple hyperplasias and papillary and nodular hyperplasias of the urothelium in the urinary bladder and tumor promotion with catechol resulted in induction of hyperkeratosis/parakeratosis and hyperplasias in the forestomach, and hyperplastic foci in the glandular stomach (Taniai et al., 2012b) .
With regard to animal study of AOM-induced colon carcinogenesis model in Experiment 6, multiple adenomas and carcinomas were developed in the colorectum and duodenum (Kikuchihara et al., 2015) .
In Experiment 7, there were significantly more and larger GST-P þ foci compared with untreated controls after TAA treatment for 28 and 90 days and MP treatment for 90 days (Supplementary Table 5 )
Immunolocalization of TMEM70 in GST-P 1 Proliferative Lesions in Experiments 1-3 In Experiments 1 and 2, DEN-alone group showed cytoplasmic expression of TMEM70 in liver cells outside the GST-P þ foci in the liver. Majority of GST-P þ foci in this group also showed cytoplasmic expression of TMEM70 in liver cells; however, minor population of GST-P þ foci showed decreased cytoplasmic expression, forming TMEM70 À foci (Supplementary Figure 1) . Following tumor promotion for 6 or 8 weeks, all hepatocarcinogens/hepatocarcinogenic tumor promoters significantly increased population of GST-P þ foci downregulating TMEM70 expression compared with DEN-alone group.
In Experiment 3, all of proliferative lesions produced by promotion with TAA for 30 weeks and diagnosed as liver cell foci, adenomas or carcinomas by histopathological analysis of hematoxylin and eosin-stained sections showed GST-P þ immunoreactivity. As previously shown, TMEM70 showed positive immunoreactivity in liver cells surrounding GST-P þ proliferative lesions similar to tumor promoted livers in Experiments 1 and 2 (Supplementary Figure 2) . Within the GST-P þ proliferative lesions, TMEM70 showed lack of expression and the incidence of TMEM70 -in GST-P þ lesions was significantly higher with adenomas and carcinomas than with liver cell foci.
Immunolocalization of ATPB, HSP60, GLUT1 and G6PD in GST-P 1
Foci in Experiments 1 and 2
In DEN-alone group, ATPB showed cytoplasmic expression in liver cells outside the GST-P þ foci. Most of GST-P þ foci in this group also showed cytoplasmic expression of ATPB in liver cells;
however, very minor population of GST-P þ foci showed decreased cytoplasmic expression of ATPB, forming ATPB -foci ( Figure 1A ). Following tumor promotion for 6 or 8 weeks, population of GST-P þ foci downregulating ATPB expression was increased and incidences of ATPB -foci in GST-P þ foci significantly increased in every promoted group compared with DENalone group ( Figure 1A) . With regard to HSP60, DEN-alone group showed cytoplasmic expression in both GST-P þ liver cell foci and surrounding liver cells ( Figure 1A) . Following tumor promotion for 6 or 8 weeks, most or all population of GST-P þ foci showed cytoplasmic expression with unchanged expression intensity compared with surrounding liver cells. Very minor population of GST-P þ foci in DEN þ TAA group (week 6) or DEN þ FB group (week 8) showed HSP60 downregulation or upregulation accompanying statistically significant difference as compared with DEN-alone group. With regard to GLUT1, DEN-alone group showed faint cytoplasmic and cell membrane expression of GLUT1 in liver cells. Although most of GST-P þ foci showed similar expression with the surrounding liver cells, minor population of GST-P þ foci
showed strong immunoreactivity of GLUT1 in cell membrane, forming GLUT1 þ foci ( Figure 1A ). Following tumor promotion for 6 or 8 weeks, population of GST-P þ foci upregulating membranous GLUT1 expression was increased and incidence of GLUT1 þ foci in GST-P þ foci was significantly higher in every promoted group compared with DEN-alone group ( Figure 1A ). With regard to G6PD, DEN-alone group showed cytoplasmic expression in liver cells within the minor population of GST-P þ foci but not in liver cells surrounding GST-P þ foci ( Figure 1A ).
Following tumor promotion for 6 or 8 weeks, population of GST-P þ foci upregulating G6PD expression was increased and incidences of G6PD þ foci in GST-P þ foci significantly increased in every promoted group compared with DEN-alone group ( Figure 1A) .
Immunolocalization of ATPB, GLUT1 and G6PD in GST-P 1
Proliferative Lesions in Experiment 3 ATPB showed cytoplasmic expression in liver cells outside the GST-P þ proliferative lesions produced by promotion with TAA for 30 weeks similar to tumor promoted livers for short terms in Experiments 1 and 2. Within the GST-P þ proliferative lesions, ATPB showed lack of expression and the incidence of ATPB -in GST-P þ lesions was significantly higher with adenomas and carcinomas than with liver cell foci ( Figure 1B) . With regard to GLUT1, faint cytoplasmic and cell membrane expression was observed in liver cells surrounding the GST-P þ proliferative lesions similar to tumor promoted livers for short terms in Experiments 1 and 2. Within the GST-P þ proliferative lesions, GLUT1 showed strong immunoreactivity in cell membrane and the incidence of membranous GLUT1 þ in GST-P þ lesions was significantly higher with adenomas and carcinomas than with liver cell foci ( Figure 1B) . With regard to G6PD, cytoplasmic expression was observed in GST-P þ proliferative lesions accompanying lacked expression in liver cells surrounding GST-P þ lesions similar to tumor promoted livers for short terms in Experiments 1 and 2. The incidence of G6PD þ in GST-P þ lesions was significantly higher with carcinomas than with liver cell foci ( Figure 1B) .
Immunolocalization of ATPB, GLUT1 and G6PD in TMEM70 -Foci in Experiments 1 and 2
In DEN-alone group, ATPB showed downregulation of expression in minor population of TMEM70 -foci; however, the majority of TMEM70 -foci showed unchanged expression intensity of ATPB compared with surrounding liver cells. Following tumor promotion for 6 or 8 weeks, population of TMEM70 -foci downregulating ATPB expression was increased and incidence of ATPB -/TMEM70 -foci was significantly higher in every promoted group compared with DEN-alone group ( Figure 1C) . With regard to GLUT1, although most of TMEM70 -foci showed unchanged expression intensity compared with surrounding liver cells, very minor population of TMEM70 -foci increased membranous GLUT1 immunoreactivity in DEN-alone group. Following tumor promotion for 6 or 8 weeks, population of TMEM70 -foci upregulating membranous GLUT1 expression was increased and incidence of GLUT1 þ /TMEM70 -foci was significantly higher in every promoted group compared with DENalone group ( Figure 1C) . With regard to G6PD, all of TMEM70 -foci showed unchanged expression intensity compared with surrounding liver cells in DEN-alone group. Following tumor promotion for 6 or 8 weeks, population of TMEM70 -foci upregulating G6PD expression was increased and incidence of G6PD 
Immunolocalization of TMEM70 and Cellular Metabolism-Related Molecules in Proliferative Lesions in Experiments 4-6
In Experiment 4, all of altered liver cell foci that have nonimmunoreactivity with GST-P produced by tumor promotion with CF or DEHP as PPARa agonist showed cytoplasmic expression of TMEM70 revealing unchanged expression intensity compared with surrounding liver cells (Supplementary Figure 3) . With regard to cellular metabolism-related molecules, expression of ATPB, GLUT1, and G6PD showed unchanged expression intensity compared with surrounding liver cells (data not shown).
In Experiment 5, all of proliferative lesions produced in the thyroid, urinary bladder, forestomach and glandular stomach showed cytoplasmic expression of TMEM70 showing unchanged expression intensity compared with surrounding parenchymal cells (Supplementary Figure 4) . With regard to cellular metabolism-related molecules, expression of ATPB, GLUT1, and G6PD showed unchanged expression intensity compared with surrounding parenchymal cells (data not shown).
In Experiment 6, all of colorectal and duodenal tumors examined showed expression of TMEM70 with variable staining intensity within each tumor (Supplementary Figure 5) . With regard to cellular metabolism-related molecules, expression of ATPB was variable in staining intensity within each tumor, similar to the expression pattern of TMEM70 (data not shown). GLUT1 and G6PD showed unchanged expression intensity compared with surrounding parenchymal cells (data not shown). (B) cleaved caspase 3 þ apoptosis (Â20 objective), and (C) phosphorylated c-MYC þ cells (Â40 objective) in an animal of DEN þ TAA group. Graphs show the number of cells expressing each molecule (value, mean þ SD, n ¼ 10) in ATPB þ/-and ATPB -foci in combination, GLUT1 þ/-and GLUT1 þ foci in combination, or G6PD þ/-and G6PD þ foci in combination (open column: decreased; shaded column: unchanged; filled column: increased) in each promoted group. Bar ¼ 50 lm (PCNA and phosphorylated c-MYC) or 100 lm (cleaved caspase 3). **p < .01, significantly different from the ATPB þ/-/TMEM70 -/GST-P þ foci in each group by Student's or Aspin-Welch's t test (PCNA). † † p < .01, significantly different from the GLUT1 þ/-/TMEM70 -/GST-P þ foci in each group by Student's or Aspin-Welch's t test (phosphorylated c-MYC).
Transcript Expression Changes after Treatment With Hepatocarcinogen or Non-Carcinogenic Hepatotoxicant for 28 or 90 Days
In Experiment 7, transcript levels of the genes listed in Supplementary Table 2 at days 28 and 90 were determined by real-time RT-PCR in TAA, MP, and PMZ groups and compared with the levels in untreated controls (Table 2 ). Transcript level of Tmem70 at day 28 significantly decreased in TAA and MP groups after normalization with Actb and Hprt1 compared with untreated controls. At day 90, Tmem70 transcript level significantly decreased in TAA group after normalization with Actb and Hprt1 and in MP group after normalization with Hprt1 compared with untreated controls. Transcript level of Atp5b at day 28 significantly decreased in TAA and MP groups after normalization with Actb and Hprt1 and in PMZ group after normalization with Hprt1 compared with untreated controls. At day 90, transcript level of Atp5b was unchanged in all treatment groups examined compared with untreated controls. With regard to genes encoding glucose transporters, the transcript level of Slc2a1 at day 28 significantly decreased in MP and PMZ groups after normalization with Actb and Hprt1 and in TAA group after normalization with Hprt1 compared with untreated controls. At day 90, transcript level of Slc2a1 increased in MP group and decreased in PMZ group after normalization with Hprt1 compared with untreated controls. The transcript level of Slc2a2 at day 28 significantly decreased in MP and PMZ groups after normalization with Actb and Hprt1 compared with untreated controls. At day 90, transcript level of Slc2a2 significantly increased in TAA group after normalization with Actb compared with untreated controls. With regard to genes encoding glycolytic enzymes, Hk1 expression level at day 28 significantly decreased in MP group after normalization with Actb and Hprt1 and in PMZ group after normalized with Hprt1 compared with untreated controls. At day 90, transcript level of Hk1 significantly increased in TAA group after normalization with Actb and Hprt1 and in MP group after normalization with Actb compared with untreated controls. Transcript level of Hk2 at day 28 was unchanged in all treatment groups compared with untreated controls. At day 90, transcript level of Hk2 significantly increased in TAA group after normalization with Actb and Hprt1 and decreased in PMZ group after normalization with Hprt1 compared with untreated controls. Transcript level of Hk3 at day 28 G6pd, glucose-6-phosphate dehydrogenase; Hif1a, hypoxia inducible factor 1 alpha subunit; Hk, hexokinase; Hprt1, hypoxanthine phosphoribosyltransferase 1; MP, methapyrilene hydrochloride; Myc, MYC proto-oncogene, bHLH transcription factor; Pgam1, phosphoglycerate mutase 1; Pklr, pyruvate kinase, liver and RBC; Pkm, pyruvate kinase, muscle; PMZ, promethazine hydrochloride; Slc2a1, solute carrier family 2 member 1; Slc2a2, solute carrier family 2 member 2; TAA, thioacetamide; Tmem70, transmembrane protein 70.
Data are expressed as the mean 6 SD. 
DISCUSSION
In rat hepatocarcinogenesis, we previously found TMEM70 downregulation in GST-P þ proliferative lesions from early preneoplastic to late stage neoplastic lesions (Mizukami et al., 2017) . In this study in rats, we found that all GST-P -liver cell foci produced by tumor promotion with PPARa agonists showed cytoplasmic TMEM70, ATPB, GLUT1, and G6PD expression, which was unchanged compared with surrounding liver cells. With regard to the possible involvement of loss of TMEM70 function in the carcinogenic process targeting other organs, all of the early proliferative lesions produced in the thyroid, urinary bladder, forestomach, and glandular stomach using 2-stage carcinogenesis models showed that expression of TMEM70, ATPB, GLUT1, and G6PD was unchanged compared with surrounding parenchymal cells. Although colorectal and duodenal tumors showed expression of TMEM70 and ATPB with variable staining intensity within tumors, expression of GLUT1 and G6PD was unchanged compared with surrounding parenchymal cells. These results suggest that involvement of TMEM70 downregulation is limited to the hepatocarcinogenic process producing GST-P þ proliferative lesions.
In this study, the number of ATPB-downregulated foci among GST-P þ liver cell foci was increased by short-term tumor promotion in parallel with TMEM70 downregulation, and the incidence of ATPB -proliferative lesions among GST-P þ lesions was increased in adenomas and carcinomas compared with liver cell foci induced by long-term TAA-promotion. TMEM70 may play a role in the biogenesis of mitochondrial ATP synthase, also known as complex V, which is the final enzyme in the oxidative phosphorylation chain (Hejzlarov a et al., 2011) . With respect to carcinogenesis, ATP synthase is downregulated in many types of cancer (Isidoro et al., 2004) . Therefore, our results suggest functional linkage of TMEM70 with the downregulation of ATP synthase during early hepatocarcinogenesis. Conversely, in this study the immunoreactivity of HSP60, a constitutively expressed mitochondrial marker (Samali et al., 1999) , in GST-P þ liver cell foci was unchanged compared with surrounding liver cells. These results suggest an increase in the number of GST-P þ liver foci with reduced ATP synthase in mitochondria, but not with a reduced number of mitochondria, in the early stage of tumor promotion. Moreover, tumor promotion also increased the number of PCNA þ proliferating cells in ATPB
synthase controls the extent of mitochondrial oxidative damage from oxidative phosphorylation in normal cells and suppression of ATP synthase function results in production of reactive oxygen species, which play a key role in cell proliferation mediated by NFjB activation (Formentini et al., 2012) . This suggests that ATP synthase downregulation facilitates NFjB-mediated cell proliferation. Thus, reducing mitochondrial oxidative phosphorylation may facilitate cell proliferation as a hepatocarcinogenic mechanism.
In this study, we found that tumor promotion increased the number of both GLUT1 þ /GST-P þ foci and G6PD þ /GST-P þ foci, and the incidence of proliferative lesions immunoreactive for GLUT1 or G6PD in GST-P þ lesions was increased in adenomas and/or carcinomas compared with preneoplastic liver cell foci induced by long-term TAA treatment. These results suggest that facilitation of glycolysis plays a role in the early stage of hepatocarcinogenesis. Moreover, tumor promotion also increased the number of GLUT1
-/GST-P þ foci, and among them, GLUT1 þ / TMEM70 -/GST-P þ foci had increased numbers of cells with nu-
c-MYC, a well-known driver of cell proliferation, stimulates glycolysis by activating expression of glucose transporters and glycolytic enzymes (Osthus et al., 2000) . In contrast, an increased glucose flux promotes O-linked N-acetylglucosamine modification responsible for c-MYC stabilization and its transcriptional activation (Gabriel and Kallies, 2016) , suggesting a positive-feedback regulatory mechanism in glycolysis. These results suggest facilitation of glycolysis through c-MYC-mediated transcription activation in liver cell foci showing loss of function of mitochondrial oxidative phosphorylation. Furthermore, these findings provide persuasive evidence that cancer cells tend to synthesize ATP mainly through glycolysis despite the presence of oxygen, via the "Warburg effect" (Warburg et al., 1927) . It has long been debated why cancer cells select a more inefficient metabolism for ATP production than oxidative phosphorylation. One possible explanation is that an end product of glycolysis, lactic acid, is essential for cytosolic acidification, which promotes cell proliferation (Shrode et al., 1997) . Another possible explanation is that cancer cells needing to produce new cells use glucose not for energy production but for production of intermediate metabolites, eg, nicotinamide adenine dinucleotide phosphate and acetyl-CoA (Vander Heiden et al., 2009 ).
In the repeated dose toxicity study, treatment of rats with hepatocarcinogen, TAA or MP, downregulated liver transcript levels of Tmem70 at both day 28 and day 90. In contrast, transcript upregulation was observed on genes encoding glucose transporters and glycolytic enzymes, as well as Myc by TAA treatment from day 28 and by MP treatment at day 90. Interestingly, GST-P þ liver cell foci started to appear at day 28 by TAA treatment and at day 90 by MP treatment. These results suggest reduction of mitochondrial oxidative phosphorylation in liver cells precedes activation of glycolysis to undergo a metabolic shift during the stage before starting to produce proliferative lesions by repeated hepatocarcinogen treatment. It is well known that c-MYC is associated with tumorigenesis through transcriptional activation of genes regulating cell proliferation and cell cycle progression (Schmidt, 1999) . Carcinogenic stresses cause cell cycle arrest, an atypical feature of cellular senescence (Campisi, 2013) . We have also previously reported that hepatocarcinogen treatment of rats for 28 days increased cell cyclearrested liver cells (Yafune et al., 2013; Kimura et al., 2016) . Considering that suppression of Myc expression induces cellular senescence (Wu et al., 2007) , our results suggest that activation of c-MYC-mediated transcription facilitates glycolysis and cell proliferation after hepatocarcinogen treatment for only 28 days, which promotes escape from cellular senescence and advancement to carcinogenesis. Among genes encoding glucose transporters and glycolytic enzymes, we found expression of Pklr, which encodes pyruvate kinase isozymes L/R (PKL/PKR), was decreased after hepatocarcinogen treatment for both 28 and 90 days. In contrast, we found upregulation or a tendency for upregulation of Pkm, which encodes pyruvate kinase isozymes M1/M2 (PKM1/PKM2), after hepatocarcinogen treatment for 90 days. In normal conditions, PKL is the major isoform in the liver (Imamura and Tanaka, 1972) . In contrast, PKM2, the major isozyme in the fetus, is increased in preneoplastic liver cell foci and is accompanied by decreased PKL immunoreactivity in rat hepatocarcinogenesis (Steinberg et al., 1999) . PKM2 not only plays an essential role in aerobic glycolysis, but also contributes to cell-cycle progression by controlling expression of Ccnd1, which encodes cyclin D1, via phosphorylation of histone H3 and dissociation of histone deacetylase 3 (Yang et al., 2012) . Conversely, human liver cell carcinomas show aberrant methylation of PKLR (Gao et al., 2014) . Therefore, it could be suggested that Pkm is a carcinoembryonic gene, and the molecular shift from Pklr to Pkm may be the initial cellular event to reactivate cell proliferation beneficial for hepatocarcinogenesis. These findings suggest that cellular metabolism-related genes provide early detection markers of hepatocarcinogens in 28-or 90-day repeated administration studies in rodents. The molecular relationships among Tmem70, glycolytic enzyme-related genes, and Myc may play a key role in the escape from senescence to hepatocarcinogenesis.
In conclusion, we found downregulation of TMEM70 was limited to hepatocarcinogenesis-producing GST-P þ proliferative lesions in rats. This was responsible for a metabolic shift from oxidative phosphorylation to glycolysis, which disrupted cellular senescence and contributed to tumor promotion and progression. c-MYC-mediated transcription activation may be responsible for facilitation of glycolysis and cell proliferation as a TMEM70 downregulation-mediated hepatocarcinogenesis mechanism. Early onset of a catastrophic cellular senescencerelated metabolic shift beginning from depressed mitochondrial oxidative phosphorylation was found in the liver cells after repeated hepatocarcinogen treatment before preneoplastic lesion formation. These results suggest contribution of TMEM70 downregulation to the Warburg effect, which directs GST-Pexpression-linked hepatocarcinogenesis in rats.
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